Showing results (11-20 of 78) with videos related to
Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|August 30, 2018
The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's diseaseAlice Jaillard, Matthieu Vanhoutte, Aurélien Maureille, et al.Revue Neurologique|March 8, 2025
Comparing high and low amyloid producers in Alzheimer's disease: An in-depth analysisMélanie Leroy, Anne Laure Aziz, Susanna Schraen, et al.Frontiers in Neurology|September 18, 2015
Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling ApproachConstance Delaby, Audrey Gabelle, David Blum, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 3, 2023
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal functionSylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2014
Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderlyAudrey Gabelle, Susanna Schraen, Laure-Anne Gutierrez, et al.Clinical Chemistry|September 1, 2023
Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to DementiaSylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.International Journal of Molecular Sciences|December 23, 2023
Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease ContinuumSylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.International Archives of Occupational and Environmental Health|December 25, 2019
Exposure to metal fumes and circulating miRNAs in Algerian weldersImene Amrani, Nahida Haddam, Anne Garat, et al.Current Alzheimer Research|October 28, 2015
Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke CharacteristicsSolene Moulin, Didier Leys, Susanna Schraen-Maschke, et al.Neurology|October 31, 2014
Plasma β-amyloid and MRI markers of cerebral small vessel disease: Three-City Dijon studySara Kaffashian, Christophe Tzourio, Aïcha Soumaré, et al.Pageof 8